Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Neoleukin Therapeutics, Inc. (AQXP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/17/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 20% stake in Neoleukin Therapeutics, Inc.
07/19/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/23/2020 SC 13D/A BAKER BROS. ADVISORS LP reports a 10% stake in Neoleukin Therapeutics, Inc.
12/20/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/18/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/13/2019 SC 13D/A BAKER BROS. ADVISORS LP reports a 40.3% stake in Neoleukin Therapeutics, Inc.
08/07/2019 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/27/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/09/2017 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend]
09/21/2016 SC 13D/A AQUINOX PHARMACEUTICALS, INC reports a 45.1% stake in Aquinox Pharmaceuticals, Inc.
03/16/2016 SC 13D/A Form SC 13D - General statement of acquisition of beneficial ownership [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy